Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.37 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.37 |
| ▸ | NSD2 | O96028 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | PNLIP | P16233 | 1/20 | 0.37 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29355946 | 1.00 | KDM4E (0.41) | KDM4EPOLBMEN1KMT2AMTNR1B | |
| SCHEMBL30051492 | 0.89 | KDM4E (0.44) | KDM4EPOLBMEN1KMT2AMTNR1B | |
| SCHEMBL2856319 | 0.89 | KDM4E (0.44) | KDM4EPOLBMEN1KMT2AMTNR1B | |
| SCHEMBL2107689 | 0.89 | KDM4E (0.44) | KDM4EPOLBMEN1KMT2AMTNR1B | |
| SCHEMBL2107684 | 0.89 | KDM4E (0.44) | KDM4EPOLBMEN1KMT2AMTNR1B | |
| SCHEMBL9150477 | 0.89 | RAB9A (0.46) | KDM4EPOLBMEN1KMT2AMTNR1B | |
| SCHEMBL202624 | 0.89 | KDM4E (0.52) | KDM4EPOLBMEN1KMT2AMTNR1B | |
| SCHEMBL9150478 | 0.89 | RAB9A (0.46) | KDM4EPOLBMEN1KMT2AMTNR1B | |
| SCHEMBL29359491 | 0.89 | KDM4E (0.52) | KDM4EPOLBMEN1KMT2AMTNR1B | |
| SCHEMBL10390057 | 0.88 | POLB (0.48) | KDM4EPOLBMEN1KMT2AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12464971-B2 | Sowing device and method for treating seeds during planting | SYNGENTA CROP PROTECTION AG (CH) | 2025-11-11 | — | — | US | disclosed |
| US-20250241304-A1 | FUNGICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2025-07-31 | — | — | US | disclosed |
| CN-111194314-B | Microbicidal pyridine amide derivative | 先正达参股股份有限公司 | 2022-12-30 | — | — | CN | disclosed |
| US-11185074-B2 | Microbiocidal quinoline (thio)carboxamide derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-11-30 | — | — | US | disclosed |
| EP-2670239-B1 | FORMULATION FOR THE ANTIMICROBIAL AND FUNGICIDAL TREATMENT OF POLYMERIC MATERIALS, IN PARTICULAR OF PAINTS AND COATINGS | SANITIZED AG (CH) | 2015-08-12 | — | — | EP | disclosed |
| US-20150144027-A1 | PARTICULATE WOOD PRESERVATIVE AND METHOD FOR PRODUCING THE SAME | KOPPERS INC. (F/K/A KOPPERS INDUSTRIES, INC.) | 2015-05-28 | — | — | US | disclosed |
| US-8871277-B2 | Particulate wood preservative and method for producing the same | OSMOSE, INC. (US) | 2014-10-28 | — | — | US | disclosed |
| WO-2014102228-A1 | FORMULATION FOR THE ANTIMICROBIAL TREATMENT OF POLYMER COMPOSITIONS | SANITIZED AG (CH) | 2014-07-03 | — | — | WO | disclosed |
| EP-2749167-A1 | Formulation for the antimicrobial treatment of polyvinyl chloride compositions | Sanitized AG (CH) | 2014-07-02 | — | — | EP | disclosed |
| US-20130324457-A1 | 1-ARYL-5-ALKYL PYRAZOLE DERIVATIVE COMPOUNDS, PROCESSES OF MAKING AND METHODS OF USING THEREOF | AVENTIS AGRICULTURE (FR) | 2013-12-05 | — | — | US | disclosed |
| WO-1997008140-A1 | N-SULFONYLIMINODITHIO COMPOUNDS USEFUL FOR PLANT AND MATERIAL PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 1997-03-06 | — | — | WO | disclosed |
| EP-0750542-A1 | COMBINATIONS OF ACTIVE INSECTICIDE SUBSTANCES | BAYER AG (DE) | 1997-01-02 | — | — | EP | disclosed |
| WO-1996032235-A1 | TIMBER PRESERVATIVE CONTAINING A COPPER COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1996-10-17 | — | — | WO | disclosed |
| WO-1996029314-A1 | THIOCARBAMOYL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-09-26 | — | — | WO | disclosed |
| WO-1996025044-A1 | S-ARYL CYANIMIDOTHIO COMPOUNDS FOR MATERIAL PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 1996-08-22 | — | — | WO | disclosed |
| EP-0726710-A1 | STABILISATION OF IODINE COMPOUNDS USING INORGANIC SUPPORTING MATERIALS FOR USE IN MATERIAL PROTECTION | BAYER AG (DE) | 1996-08-21 | — | — | EP | disclosed |
| WO-1996010915-A1 | INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1996-04-18 | — | — | WO | disclosed |
| WO-1995034204-A1 | BACTERICIDE THIADIAZOLIDINONES | BAYER AKTIENGESELLSCHAFT (DE) | 1995-12-21 | — | — | WO | disclosed |
| WO-1995024997-A1 | COMBINATIONS OF ACTIVE INSECTICIDE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 1995-09-21 | — | — | WO | disclosed |
| WO-1995012315-A1 | STABILISATION OF IODINE COMPOUNDS USING INORGANIC SUPPORTING MATERIALS FOR USE IN MATERIAL PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 1995-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11185074-B2 | Microbiocidal quinoline (thio)carboxamide derivatives | IFNG, TLR1, IDO1 | KDM4E 1828/4885POLB 1822/4885MEN1 2747/4885 |
| US-20250241304-A1 | FUNGICIDAL COMPOUNDS | CYP1B1, CYP51A1, CYP1A1 | KDM4E 852/4885POLB 4747/4885MEN1 420/4885 |
| US-20130324457-A1 | 1-ARYL-5-ALKYL PYRAZOLE DERIVATIVE COMPOUNDS, PROCESSES OF MAKING AND METHODS OF USING THEREOF | CBR3, CBR1, NR5A2 | KDM4E 3120/4885POLB 4213/4885MEN1 3084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.